Repeated administration of autogenous vaccine decreases papillomatosis in female bovines

La administración de autovacuna La administración repetida de vacuna autógena disminuye la papilomatosis en hembras bovinas

Objective. The present study aimed to evaluate the control of bovine papillomatosis (BP) with autogenous vaccine under the tropical conditions of Guerrero State. Materials and methods. In the experiment 18 bovine females were used, that were divided into three treatments according to the ranch (6 females / group). Treatment 1 (T1-immune vaccine), treatment 2 (T2-histovaccine) and treatment 3 (T3-plasma therapy). Results. At the beginning of the study, a high incidence of papillomas was found in bovine females [(T1 (190 papillomas), T2 (95 papillomas) and T3 (100 papillomas)]. With the administration of the autogenous vaccine, the number of papillomas decreased significantly (T1 and T3) through the applications from 1 (147 and 66 papillomas) to 5 (10 and 9 papillomas); (p<0.05). There was also a significant difference between treatments according to the period of application of the vaccine (3 to 5), decreasing the number of papillomas (period effect; p<0.05). On the other hand, a treatment x period interaction was observed, decreasing the number of papillomas in the fourth and fifth administration (T1 and T3; p<0.05). Conclusions. The repeated administration of the autogenous vaccine in bovine females decreased the number of papillomas between the fourth and fifth application in treatments 1 and 3.

1. Orantes-Zebadúa MA, Platas-Rosado D, Córdova-Avalos V, De Los Santos-Lara M, Córdova-Avalos A. Caracterización de la ganadería de doble propósito en una región de Chiapas, México. Ecosist Rec Agrop. 2014; 1(1):49-58. https://era.ujat.mx/index.php/rera/issue/view/88
2. Espinosa-García JA, Góngora-González SF, García-Martínez A, Cervantes-Escoto FC, Mancilla-Rendón ME, Rangel-Quintos V. Estado del arte sobre la investigación e innovación tecnológica en ganadería bovina tropical. CONACYT: México; 2015. http://www.uco.es/zootecniaygestion/img/pictorex/15_13_27_CL_22.pdf
3. Jelínek R, Tachezy R. Cutaneous papillomatosis in cattle. J Comp Pathol. 2005; 132(1):70–81. https://doi.org/10.1016/j.jcpa.2004.07.001
4. Shafti-Keramat S, Schellenbacher C, Handisurya A, Christensen N, Reininger B, Brandt, S, et al. Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes. Virology. 2009; 393(1):1–6. https://doi.org/10.1016/j.virol.2009.07.036
5. Maiolino P, Ozkul A, Sepici-Dincel A, Roperto F, Yücel G, Russo V, et al. Bovine papillomavirus type 2 infection and microscopic patterns of urothelial tumors of the urinary bladder in water buffaloes. Biomed Res Int. 2013; 2013:937918. http://dx.doi.org/10.1155/2013/937918
6. Ng T, Miller M, Kondov N, Dodd E, Batac F, Manzer M, et al. Oral papillomatosis caused by Enhydra lutris papillomavirus 1 (ElPV-1) in southern sea otters (Enhydra lutris nereis) in California, USA. J Wildl Dis. 2015; 51(2):446–453. https://doi.org/10.7589/2014-06-152
7. Bravo I, Sanjosé S, Gottschling M. The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol. 2010; 18(10):432–438. https://doi.org/10.1016/j.tim.2010.07.008
8. Lucena R, Rissi D, Kommers G, Pierezan F, Oliveira-Filho J, Macêdo J, et al. A retrospective study of 586 tumours in Brazilian cattle. J Comp Pathol. 2011; 145(1):20–24. https://doi.org/10.1016/j.jcpa.2010.11.002
9. Borzacchiello G. Roperto F. Bovine papillomaviruses, papillomas and cancer in cattle. Vet Res. 2008; 39(5):45. https://doi.org/10.1051/vetres:2008022
10. Buck C, Day P, Trus B. The papillomavirus major capsid protein L1. Virology. 2013; 445(1-2):169–174. https://doi.org/10.1016/j.virol.2013.05.038
11. Borzacchiello G. Bovine papillomavirus infections in animals. Commun Curr Res Educ Top Trends Appl Microbiol. 2007: 673–679. https://doi.org/10.1590/1678-4685-GMB-2016-0128.
12. Linsey CJ, Almeida ME, Vicari CF, Carvalho A, Yaguiu A, Freitas AC, et al. Bovine papillomarivus DNA in milk, blood, urine, semen and spermatozoa of bovine papillomavirus-infected animals. Genet Mol Res. 2009; 8(1):310–318. https://doi.org/10.4238/vol8-1gmr573.
13. Aricapa HJ, Dussan C, Marique H. Evaluación de la eficiencia de una vacuna contra la papilomatosis bovina frente a tres tratamientos diferentes. Rev Vet Zootec Cald. 2003; 12(2):48–55. http://vetzootec.ucaldas.edu.co/
14. Avki S, Turutoglu H, Simsek A, Unsal A. Clinical and immunological effects of Newcastle disease virus vaccine on bovine papillomatosis. Veterin Immunol Immunopathol. 2004; 98(1-2):9–16. https://doi.org/10.1016/j.vetimm.2003.10.003.
15. Hemmatzadeh F, Fatemi A, Amini F. Therapeutic effects of fig tree latex on bovine papillomatosis. J Veterin Med. Infect Diseas Veterin Pub Healt. 2003; 50(10):473–476. https://doi.org/10.1046/j.1439-0450.2003.00702.x
16. Börkü MK, Atalay O, Kibar M, Cam Y, Ata-sever A. Ivermectin is an effective treatment for bovine cutaneous papillomatosis. Res Veterin Sci. 2007; 83(3):360–363. https://doi.org/10.1016/j.rvsc.2007.01.016.
17. García E. Modificaciones al sistema de clasificación climática de Köeppen. 2da ed. Instituto de Geografía, Universidad Nacional Autónoma de México: México, D.F; 1973. http://www.publicaciones.igg.unam.mx/index.php/ig/catalog/book/83.
18. SAS Institute, SAS/STAT. 2004. User’s guide statistics released 9.1 (2nd Ed.) SAS Institute, Inc. Cary. in:https://support.sas.com/documentation/onlinedoc/91pdf/sasdoc_91/share_ug_7261.pdf
19. NAM. Guide for the care and use of laboratory animals. Co-produced by the National Academy of Medicine-Mexico and the Association for assessment and accreditation of laboratory animal care international. 1st. Edition. Harlan: Mexico; 2002. https://grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animals.pdf
20. FASS. Guide for the care and use of agricultural animals in agricultural research and teaching. 3rd edition. Federation Animal Science Society: Savoy, USA; 2010. https://www.adsa.org/Publications/FASS-2010-Ag-Guide.
21. Violet LL, Montes VD, Cardona AJ. Frecuencia de papilomatosis en bovinos (Bos taurus) del departamento de Córdoba, Colombia. Rev Colomb Cienc Anim - RECIA. 2017; 9(Supl 2):294–300. https://doi.org/10.24188/recia.v9.n2.2017.611
22. Özyurtlu N, Aslan S. Homeopati ve Veteriner Hekimliginde Kullanimi. Veteriner Hekimler Dernegi Dergisi. 2007; 78(1):39–42. https://doi.org/10.18805/ijar.5586
23. Campo M. Vaccination against papillomavirus in cattle. Clin Dermatol. 1997; 15(2):275–283. https://doi.org/10.1016/S0738-081X(96)00165-4
24. Rojas-Anaya E, Cantú-Covarrubias A, Morales-Álvarez JF. Detection and phylogenetic analysis of bovine papillomavirus in cutaneous warts in cattle in Tamaulipas, Mexico. Can J Vet Res. 2017; 80(4):262–268. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052877/pdf/cjvr_10_262.pdf
25. Catroxo M, Martins A, Petrella S, Souza F, Nastari B. Ultrastructural study of bovine papillomavirus during outbreaks in Brazil. Internat J Morphol. 2013; 3(2):777–784. http://dx.doi.org/10.4067/S0717-95022013000200068
26. Reis M, Slaviero M, Lorenzett M, Cruz R, Guimarães L, Pavarini S, et al. Neoplasmas bovinos diagnosticados no Setor de Patologia Veterinária da UFRGS, Porto Alegre (2005-2014). Pesquisa Vet Bras. 2017; 37(2):105–109. https://doi.org/10.1590/s0100-736x2017000200002
27. Roperto S, Borzacchiello G, Esposito I, Riccardi M, Urraro C, Cermola M, et al. Productive infection of bovine papillomavirus type 2 in the placenta of pregnant cows affected with urinary bladder tumors. PLoS One. 2012; 7:e33569. https://doi.org/10.1371/journal.pone.0033569
28. Lunardi M, Alcântara B, Otonel R, Rodrigues W, Alfieri A, Alfieri A. Bovine papillomavirus type 13 DNA in equine sarcoids. J Clin Microbiol. 2013; 51(7):2167–2171. https://doi.org/10.1128/JCM.00371-13.
29. Savini F, Mancini S, Gallina L, Donati G, Casá G, Peli A, et al. Bovine papillomatosis: First detection of bovine papilloma-virus types 6, 7, 8, 10 and 12 in Italian cattle herds. Rev Vet J. 2016; 210:82–84. https://doi.org/10.1016/j.tvjl.2016.02.003.
30. Foldvari M, Kumar P. Recent progress in the application of nanotechnology for prevention and treatment of human papillomavirus infection. Ther Deliv. 2012; 3(8):1005–1017. https://doi.org/10.4155/tde.12.78.